Illumina Win Over BGI Upheld as Judge Blocks Gene Sequencers (2)

March 28, 2022, 4:30 PM UTCUpdated: March 28, 2022, 7:34 PM UTC

Illumina Inc. won an order blocking BGI Genomics Co., the world’s largest commercial genetic sequencer, from selling some of its sequencers in the U.S. until after the expiration of patents at issue in a California dispute Illumina won last November.

Judge William H. Orrick’s Sunday night order in the U.S. District Court for the Northern District of California also upheld a San Francisco jury’s November verdict awarding Illumina $8 million for a BGI unit’s infringement of genetic-sequencing patents. The order resolved a spate of issues in two suits between the rivals, including by its denial of BGI’s bid ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.